(Press-News.org) Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, intermediate-risk cervical carcinoma indicated that the addition of chemotherapy did not improve outcomes for patients and led to increased toxicity for patients. The outcomes of this trial support the use of the current standard of care using adjuvant radiotherapy alone following surgery. These results were presented during the Plenary Session of the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer in Seattle, Washington.
“Despite the negative outcome of this study for improving recurrence-free survival in this population, there are still key takeaways we can learn from to help redirect future research.“ stated Sang Young Ryu, MD, of the Department of Gynecologic Oncology at the Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences and the lead author of the NRG-GOG 0263 abstract.
The NRG-GOG-0263 study did not meet its primary objective of improving recurrence-free survival through the addition of cisplatin chemotherapy. The trial accrued 316 eligible patients with early-stage disease and intermediate-risk factors including a combination of histopathologic factors such as capillary lymphatic space involvement, stromal invasion, and tumor size. Accrued patients had radical hysterectomy prior to enrollment onto the study. Trial participants were randomly assigned to receive either adjuvant chemo-radiotherapy (CRT) or radiotherapy alone (RT).
Ninety-two percent of patients had 28 fractions of radiation with median dosage of 50.4 Gy and duration of 39 days, and 91% of the patients in CRT arm received at least 4 cycles of weekly cisplatin. The 3-year recurrence-free survival estimates for the CRT and RT arms were 88.5% (95% CI: 82% – 93%) and 85.4% (95% CI: 79% – 90%). The recurrence-free survival hazard ratio estimate for CRT vs RT was 0.6976 (95% CI: 0.408-1.192, p = 0.0927). The estimated overall survival hazard ratio for the CRT vs RT arm was 0.586 (95% CI: 0.286 - 1.199, p = 0.0695). Grade 3 or 4 adverse events occurred in 15% and 43% of RT and CRT arms respectively (p < 0.0001).
“At this time, women with early-stage disease and intermediate-risk factors are treated with radiotherapy alone. Chemotherapy has been considered as an addition to this treatment, based on prior clinical data indicating it could potentially improve outcomes for these women. The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative. Future research needs to elaborate whether the timing of chemotherapy can improve outcomes, or if another alternative can be considered to help improve on the results of this trial while limiting toxicity,” Dr. Ryu added.
This study was supported by the National Cancer Institute (NCI), part of the National Institutes of Health, and was supported by grants U10CA180822 (NRG Oncology SDMC) and U10CA180868 (NRG Oncology Operations) from the NCI.
Citation
Ryu SY, Deng W, Albuquerque K, Koh W, Mayadev JS, Heugel A, Kim B, Kim D, Cho C, Kim J, No JH, Mannel RS, Miller K, Fabian D, Small W, Rodgers W, Leath CA, Monk B. Randomized Phase III Trial of Adjuvant Radiation Versus Chemo-Radiation in Intermediate-Risk, Early-Stage Cervical Carcinoma following Radical Hysterectomy and Lymphadenectomy (Results of NRG Oncology/GOG-263). SGO (Society of Gynecologic Oncology). 3/14/2025. Plenary Session Oral Presentation.
About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs. The research network seeks to carry out clinical trials with emphases on gender-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology’s extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI’s National Clinical Trials Network.
www.nrgoncology.org
END
NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer
2025-03-15
ELSE PRESS RELEASES FROM THIS DATE:
Introducing our new cohort of AGA Future Leaders
2025-03-14
We’re thrilled to announce the 16 distinguished early-career gastroenterologists and hepatologists selected for our 2025-2026 class of AGA Future Leaders. This AGA program cultivates effective leadership skills for professional advancement in AGA and within the field of digestive diseases.
Meet the AGA Future Leaders Class of 2025-2026
Lubin Arevalo, MD
Veroushka Ballester, MD, MS
Victor Chedid, MD, MS
Ryan Fawley, MD
Melissa Hershman, MD
Pichamol Jirapinyo, MD, MPH
Babu Pappu Mohan, MD
Carolyn Newberry, MD
Long ...
Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help
2025-03-14
Despite the fear they may inspire in humans, sharks have far more reason to fear us. Nearly one-third of sharks are threatened with extinction globally, mostly as a result of fishing.
A team led by researchers at UC Santa Barbara discovered that mandates to release captured sharks won’t be enough to prevent the continued decline of these important ocean predators. These findings, published in Fish & Fisheries, highlight the importance of monitoring shark populations and combining different strategies for managing their numbers.
Some ...
Engineering excellence: Engineers with ONR ties elected to renowned scientific academy
2025-03-14
Three esteemed engineers with ties to the Office of Naval Research (ONR) have been elected to the prestigious National Academy of Engineering (NAE) Class of 2025. NAE members are among the world’s most accomplished engineers from business, academia and government.
“On behalf of the Office of Naval Research, I’m proud to extend my sincerest congratulations to these new members of the National Academy of Engineering,” said Chief of Naval Research Rear Adm. Kurt Rothenhaus. “Not only have these accomplished engineering professionals supported and conducted valuable naval-relevant research, they’re also enhancing the strength and prosperity of our nation by serving ...
New CRISPR-based diagnostic test detects pathogens in blood without amplification
2025-03-14
Bioengineering professor and The Grainger College of Engineering’s Dean, Rashid Bashir, led a team of researchers in a project that’s resulted in new technology that offers rapid, highly sensitive detection of multi-drug-resistant bacteria and other pathogens at low concentrations.
This research was featured in an article in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Researchers designed a CRISPR-based test that rapidly detects low levels of pathogen genetic material in blood. This is done without the need for nucleic acid amplification.
In ...
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
2025-03-14
PHILADELPHIA – Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer than the same targeted therapy by itself, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center. The results, published in Cancer Discovery, prime the combination strategy for future clinical trials.
Combatting the “undruggable” ...
Growing solar: Optimizing agrivoltaic systems for crops and clean energy
2025-03-14
Agrivoltaic systems, which combine solar power generation with agricultural practices, offer a promising solution to the growing demand for both renewable energy and food production. By integrating solar panels with crops, these systems not only address the land use conflict between agriculture and energy production, but they also provide important benefits such as reducing crop water stress and offering protection against extreme weather events. In addition, agrivoltaics can contribute to biodiversity by providing pollinator habitats and forage production. ...
Scientists discover how to reactivate cancer’s molecular “kill switch”
2025-03-14
Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different versions of a film. By selecting which scenes to keep and which to leave out, the editor can produce a drama, a comedy, or even a thriller—all from the same raw material. Similarly, cells splice RNA in different ways to produce a variety of proteins from a single gene, fine-tuning their function based on need. However, when cancer rewrites the script, this process goes awry, fueling tumor growth and survival.
In a recent study reported in the Feb. 15 issue of Nature ...
YouTube influencers: gaming’s best friend or worst enemy?
2025-03-14
New INFORMS Marketing Science Study Key Takeaways:
YouTube influencers increase player engagement and playtime but often reduce game purchases, especially for story-driven games.
A unique event in YouTube’s history, the “Adpocalypse,” allowed researchers to measure the causal impact of influencer content, revealing its complex effects on game sales and usage.
Game developers must align their business models with influencer marketing, because games with in-game purchases benefit from exposure, while ...
uOttawa scientists use light to unlock secret of atoms
2025-03-14
A team of researchers from the University of Ottawa has made significant strides in understanding the ionization of atoms and molecules, a fundamental process in physics that has implications for various fields including x-ray generation and plasma physics.
Think about atoms - the building blocks of everything around us. Sometimes, they lose their electrons and become charged particles (that's ionization). It happens in lightning, in plasma TVs, and even in the northern lights. Until now, scientists thought they could only control this process in limited ways.
Led by Ravi Bhardwaj, Full Professor at uOttawa’s Department of Physics, and PhD student Jean-Luc Begin, in collaboration ...
NJIT mathematician to help map Earth's last frontier with Navy grant
2025-03-14
We’ve mapped nearly all of Mars’ surface from orbit, yet we know less about Earth’s ocean floor — almost 75% remains unmapped in high resolution.
This terrestrial blind spot is driving NJIT Mathematics Professor Eliza Michalopoulou’s latest research, funded by the Office of Naval Research (ONR). The project aims to improve how scientists explore the vast, uncharted ocean floor through sound.
“Mapping the seabed is a challenging endeavor due to the extreme conditions,” said Michalopoulou, ...